Skip to main content

Pacific Biosciences of California

Pacific Biosciences of California Inc, operating as PacBio, is an American biotechnology equipment company delivering long-read DNA sequencing systems. The company designs, manufactures, and markets Single Molecule, Real-Time (SMRT) and short-read sequencing platforms, including the Revio and Onso sequencing systems, alongside sequencing reagent kits. Main revenue drivers consist of commercial sales of high-throughput DNA sequencing instruments, single-use chemical reagent kits, and technical maintenance service contracts. PacBio serves academic research institutes, genome centers, agricultural biotechnology firms, clinical diagnostic labs, and biopharmaceutical corporations globally. The company holds a world-dominant market position in highly accurate long-read DNA sequencing technology. Headquartered in Menlo Park, California, Pacific Biosciences of California Inc is listed on the Nasdaq Stock Market.

2 of the funds FundTelligence covers report a position in Pacific Biosciences of California.

Legal name
PACIFIC BIOSCIENCES OF CALIFORNIA
Sector
Health Care
Country
United States
Funds holding it
2
Exposure themes
Genomics & Profiling, Precision Medicine & Genomics, Sequencing

Funds holding Pacific Biosciences of California

Loading...